GDNF Gene Therapy for Multiple System Atrophy

Recruiting

Phase 1

GDNF Gene TherapyGDNF Gene Therapy for Multiple System Atrophy

Sponsor:

Brain Neurotherapy Bio, Inc.

Code:

NCT04680065

Conditions

Multiple System Atrophy

Eligibility Criteria

Sex: All

Age: 35 - 70+

Healthy Volunteers: Not accepted

Interventions

AAV2-GDNF gene therapy

Sham (Placebo) Surgery

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-24. This information was provided to ClinicalTrials.gov by Brain Neurotherapy Bio, Inc. on 2025-02-10.